Iqvia Holdings Inc (N:IQV)

Business Focus: Biotechnology & Medical Research

Sector:  Healthcare Industry:  Biotechnology & Medical Research
See Regulatory Filings on SEC
Company Contact
Address: 4820 Emperor Blvd
DURHAM NC 27703-8426
Tel: N/A
IR: See website
Key People
Ari Bousbib
Chairman of the Board, President, Chief Executive Officer
Michael R. McDonnell
Chief Financial Officer, Executive Vice President
Kevin C. Knightly
President - Information and Technology Solutions
Walter Richard Staub
President - Research and Development Solutions
Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Business Overview
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.
Financial Overview
For the three months ended 31 March 2019, Iqvia Holdings Inc revenues increased 5% to $2.68B. Net income decreased 16% to $58M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Other segment loss increase of 5% to $295M, Contract Sales & Medical Solutions segment income decrease of 31% to $9M.
Employees: 58,000 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $41,318M as of Mar 31, 2019
Annual revenue (TTM): $10,533M as of Mar 31, 2019
EBITDA (TTM): $1,976M as of Mar 31, 2019
Net annual income (TTM): $213.00M as of Mar 31, 2019
Free cash flow (TTM): $673.00M as of Mar 31, 2019
Net Debt Last Fiscal Year: $10,296M as of Mar 31, 2019
Shares outstanding: 197,240,698 as of Apr 26, 2019
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization